Serina Therapeutics, Inc.
SER · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $3,672 | $7,619 | $645 | $584 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $4 | $25 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2,004 | $0 | $1,804 | $1,625 |
| Total Curr. Assets | $5,676 | $7,619 | $2,453 | $2,234 |
| Property Plant & Equip (Net) | $1,048 | $1,349 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $738 | $0 |
| Long-Term Investments | $0 | $0 | $50 | $50 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $870 |
| Total NC Assets | $1,048 | $1,349 | $788 | $920 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $6,724 | $8,968 | $3,241 | $3,154 |
| Liabilities | – | – | – | – |
| Payables | $744 | $580 | $568 | $193 |
| Short-Term Debt | $0 | $0 | $7,646 | $7,140 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $1,622 | $833 | $1,864 | $1,634 |
| Total Curr. Liab. | $2,366 | $1,413 | $10,078 | $8,967 |
| LT Debt | $268 | $3,445 | $10,478 | $6,062 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3,582 | $36,404 | $0 | $0 |
| Total NC Liab. | $3,850 | $39,849 | $10,478 | $6,062 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $268 | $462 | $0 | $0 |
| Total Liabilities | $6,216 | $41,262 | $20,556 | $15,029 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $1 | $0 | $4 | $4 |
| Retained Earnings | -$44,318 | -$33,177 | -$116,210 | -$105,748 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $44,958 | $883 | $98,994 | $93,912 |
| Total Equity | $641 | -$32,294 | -$17,212 | -$11,832 |
| Supplemental Information | – | – | – | – |
| Minority Interest | -$133 | $0 | -$103 | -$43 |
| Total Liab. & Tot. Equity | $6,724 | $8,968 | $3,241 | $3,154 |
| Net Debt | -$3,404 | -$4,174 | $17,479 | $12,618 |